C L Bogert

Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.

Gary A. Piazza, David S. Alberts, Lee J. Hixson et al. · PubMed · 1997 · 361 citations

Chemoprevention Strategy, Prostaglandin Levels, Gastrointestinal Pharmacology +16

Physical Activity, Body Mass Index, and Prostaglandin E2 Levels in Rectal Mucosa

David K. Heddens, David L. Earnest, C L Bogert et al. · JNCI Journal of the National Cancer Institute · 1999 · 111 citations · Full text

Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?

David S. Alberts, Lee J. Hixson, Dennis J. Ahnen et al. · Journal of Cellular Biochemistry · 1995 · 100 citations

Prostaglandin Precursors, Anti-inflammatory, Oncology +14

A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.

Richard J. Knapp, Linda K. Vaughn, S N Fang et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 55 citations

Effects of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: a randomized phase IIb trial.

Robert Calaluce, David L. Earnest, David K. Heddens et al. · PubMed · 2000 · 32 citations

Prostaglandin E2, Oncology, Chemoprevention Strategy +13